Solriamfetol Hydrochloride Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as AXSOME MALTA. It is marketed under 1 brand name, including SUNOSI. Available in 2 different strengths, such as EQ 75MG BASE, EQ 150MG BASE, and administered through 1 route including TABLET;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"113630","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1a33f408ce7f407f9b21","publication_number":"US20240239740A1","cleaned_patent_number":"12209059","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-07","publication_date":"2024-07-18","legal_status":"Pending"} US12209059B2 18 Jul, 2024 Pending 07 Jun, 2026
{"application_id":"1806","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1a33f408ce7f407f9b21","publication_number":"US10351517B2","cleaned_patent_number":"10351517","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-07","publication_date":"2019-07-16","legal_status":"Granted"} US10351517B2 16 Jul, 2019 Granted 07 Jun, 2026
{"application_id":"35026","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1a33f408ce7f407f9b21","publication_number":"US11753368B2","cleaned_patent_number":"11753368","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-07","publication_date":"2023-09-12","legal_status":"Granted"} US11753368B2 12 Sep, 2023 Granted 07 Jun, 2026
{"application_id":"35023","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1a33f408ce7f407f9b21","publication_number":"US9604917B2","cleaned_patent_number":"9604917","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-07","publication_date":"2017-03-28","legal_status":"Granted"} US9604917B2 28 Mar, 2017 Granted 07 Jun, 2026
{"application_id":"1803","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1a33f408ce7f407f9b21","publication_number":"US8877806B2","cleaned_patent_number":"8877806","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-07","publication_date":"2014-11-04","legal_status":"Granted"} US8877806B2 04 Nov, 2014 Granted 07 Jun, 2026
{"application_id":"35022","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1a33f408ce7f407f9b21","publication_number":"US8440715B2","cleaned_patent_number":"8440715","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-06-11","publication_date":"2013-05-14","legal_status":"Granted"} US8440715B2 14 May, 2013 Granted 11 Jun, 2031
{"application_id":"36018","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"40a20b13a77746cb90f6","publication_number":"US10195151B2","cleaned_patent_number":"10195151","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-09-05","publication_date":"2019-02-05","legal_status":"Granted"} US10195151B2 Formulation 05 Feb, 2019 Granted 05 Sep, 2037
{"application_id":"36019","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"40a20b13a77746cb90f6","publication_number":"US10512609B2","cleaned_patent_number":"10512609","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-09-05","publication_date":"2019-12-24","legal_status":"Granted"} US10512609B2 24 Dec, 2019 Granted 05 Sep, 2037
{"application_id":"35024","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1a33f408ce7f407f9b21","publication_number":"US11439597B2","cleaned_patent_number":"11439597","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-09-05","publication_date":"2022-09-13","legal_status":"Granted"} US11439597B2 Formulation 13 Sep, 2022 Granted 05 Sep, 2037
{"application_id":"109605","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"40a20b13a77746cb90f6","publication_number":"US11998639B2","cleaned_patent_number":"11998639","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-09-05","publication_date":"2024-06-04","legal_status":"Granted"} US11998639B2 Formulation 04 Jun, 2024 Granted 05 Sep, 2037
{"application_id":"112819","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"87435e39ec5a4329b4eb","publication_number":"US11865098B2","cleaned_patent_number":"11865098","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-06-01","publication_date":"2024-01-09","legal_status":"Patented case"} US11865098B2 09 Jan, 2024 Patented case 01 Jun, 2038
{"application_id":"35882","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"87435e39ec5a4329b4eb","publication_number":"US11648232B2","cleaned_patent_number":"11648232","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-06-01","publication_date":"2023-05-16","legal_status":"Granted"} US11648232B2 16 May, 2023 Granted 01 Jun, 2038
{"application_id":"35880","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"87435e39ec5a4329b4eb","publication_number":"US10959976B2","cleaned_patent_number":"10959976","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-06-01","publication_date":"2021-03-30","legal_status":"Granted"} US10959976B2 30 Mar, 2021 Granted 01 Jun, 2038
{"application_id":"35881","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"87435e39ec5a4329b4eb","publication_number":"US10912754B2","cleaned_patent_number":"10912754","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-06-01","publication_date":"2021-02-09","legal_status":"Granted"} US10912754B2 09 Feb, 2021 Granted 01 Jun, 2038
{"application_id":"36266","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"b2e607c537924538ae55","publication_number":"US11560354B2","cleaned_patent_number":"11560354","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-03-06","publication_date":"2023-01-24","legal_status":"Granted"} US11560354B2 Formulation 24 Jan, 2023 Granted 06 Mar, 2039
{"application_id":"114275","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US11857528B1","cleaned_patent_number":"11857528","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2024-01-02","legal_status":"Granted"} US11857528B2 02 Jan, 2024 Granted 19 Mar, 2040
{"application_id":"113587","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US11839599B2","cleaned_patent_number":"11839599","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2023-12-12","legal_status":"Granted"} US11839599B2 12 Dec, 2023 Granted 19 Mar, 2040
{"application_id":"113586","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US11850226B2","cleaned_patent_number":"11850226","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2023-12-26","legal_status":"Granted"} US11850226B2 26 Dec, 2023 Granted 19 Mar, 2040
{"application_id":"118540","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US11850227B2","cleaned_patent_number":"11850227","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2023-12-26","legal_status":"Granted"} US11850227B2 26 Dec, 2023 Granted 19 Mar, 2040
{"application_id":"112375","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US11969404B2","cleaned_patent_number":"11969404","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2024-04-30","legal_status":"Granted"} US11969404B2 30 Apr, 2024 Granted 19 Mar, 2040
{"application_id":"122660","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US20240252462A1","cleaned_patent_number":"12194016","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2025-01-14","legal_status":"Granted"} US12194016B2 14 Jan, 2025 Granted 19 Mar, 2040
{"application_id":"37207","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US11160779B2","cleaned_patent_number":"11160779","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2021-11-02","legal_status":"Granted"} US11160779B2 02 Nov, 2021 Granted 19 Mar, 2040
{"application_id":"114274","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US11986454B1","cleaned_patent_number":"11986454","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2024-05-21","legal_status":"Patented case"} US11986454B2 21 May, 2024 Patented case 19 Mar, 2040
{"application_id":"1815","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US20220000831A1","cleaned_patent_number":"12318362","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2025-06-03","legal_status":"Patented case"} US12318362B2 03 Jun, 2025 Patented case 19 Mar, 2040
{"application_id":"113588","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US11986455B2","cleaned_patent_number":"11986455","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2024-05-21","legal_status":"Patented case"} US11986455B2 21 May, 2024 Patented case 19 Mar, 2040
{"application_id":"37206","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US10940133B1","cleaned_patent_number":"10940133","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2021-03-09","legal_status":"Granted"} US10940133B2 09 Mar, 2021 Granted 19 Mar, 2040
{"application_id":"112451","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US11839598B2","cleaned_patent_number":"11839598","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2023-12-12","legal_status":"Granted"} US11839598B2 12 Dec, 2023 Granted 19 Mar, 2040
{"application_id":"112372","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"1fe7c851cc5e4457a574","publication_number":"US11850228B2","cleaned_patent_number":"11850228","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-03-19","publication_date":"2023-12-26","legal_status":"Granted"} US11850228B2 26 Dec, 2023 Granted 19 Mar, 2040
{"application_id":"116756","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US11771666B1","cleaned_patent_number":"11771666","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2023-10-03","legal_status":"Granted"} US11771666B2 03 Oct, 2023 Granted 30 Dec, 2042
{"application_id":"118295","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US11793776B1","cleaned_patent_number":"11793776","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2023-10-24","legal_status":"Granted"} US11793776B2 24 Oct, 2023 Granted 30 Dec, 2042
{"application_id":"121261","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US11872203B1","cleaned_patent_number":"11872203","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2024-01-16","legal_status":"Granted"} US11872203B2 16 Jan, 2024 Granted 30 Dec, 2042
{"application_id":"123996","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US11872204B1","cleaned_patent_number":"11872204","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2024-01-16","legal_status":"Granted"} US11872204B2 16 Jan, 2024 Granted 30 Dec, 2042
{"application_id":"123992","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US11779554B1","cleaned_patent_number":"11779554","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2023-10-10","legal_status":"Granted"} US11779554B2 10 Oct, 2023 Granted 30 Dec, 2042
{"application_id":"125972","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US12005036B2","cleaned_patent_number":"12005036","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2024-06-11","legal_status":"Patented case"} US12005036B2 11 Jun, 2024 Patented case 30 Dec, 2042
{"application_id":"123988","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US12036194B1","cleaned_patent_number":"12036194","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2024-07-16","legal_status":"Granted"} US12036194B2 16 Jul, 2024 Granted 30 Dec, 2042
{"application_id":"123995","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US12064411B1","cleaned_patent_number":"12064411","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2024-08-20","legal_status":"Granted"} US12064411B2 20 Aug, 2024 Granted 30 Dec, 2042
{"application_id":"126455","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US20240216302A1","cleaned_patent_number":"12090126","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2024-09-17","legal_status":"Patented case"} US12090126B2 17 Sep, 2024 Patented case 30 Dec, 2042
{"application_id":"126456","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US20240216303A1","cleaned_patent_number":"12102609","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2024-10-01","legal_status":"Pending"} US12102609B2 01 Oct, 2024 Pending 30 Dec, 2042
{"application_id":"164486","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US12263145B2","cleaned_patent_number":"12263145","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2025-04-01","legal_status":"Granted"} US12263145B2 01 Apr, 2025 Granted 30 Dec, 2042
{"application_id":"116755","ingredient":"SOLRIAMFETOL HYDROCHLORIDE","trade_name":"SUNOSI","family_id":"2bda9ebcb96b4313b0a8","publication_number":"US11771667B1","cleaned_patent_number":"11771667","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2042-12-30","publication_date":"2023-10-03","legal_status":"Granted"} US11771667B2 03 Oct, 2023 Granted 30 Dec, 2042

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Solriamfetol Hydrochloride

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.